Abstract: The present disclosure relates to sunscreen compositions that are unique in simultaneously protecting skin from heat in while blocking UV radiation. The sunscreen compositions typically include: (a) laponite; (b) one or more UV filters; (c) one or more emulsifiers; and (d) water. The sunscreen compositions are useful for protecting skin from UV damage caused by sun exposure and for preventing heat from reaching the skin. Furthermore, the present disclosure describes methods for using laponite to boost the SPF of sunscreen compositions.

Abstract: The disclosure relates to compositions and methods for improving the appearance of the skin. Compositions comprise comprising (A) (a) at least one vinyl-terminated polysiloxane and at least one hydride-functionalized polysiloxane, and (b) at least one filler; and (B) (a) at least one vinyl-terminated polysiloxane; (b) at least one filler, and (c) at least one metal catalyst. Methods comprise applying the compositions to the skin to tighten the skin or hide skin imperfections by forming a film on the skin. Kits comprising the composition are also disclosed.

Abstract: The invention relates to systems and methods for improving the appearance of the skin. The systems comprise 1) a skin-tightening composition comprising at least one thermoplastic elastomer and at least one adhesive polymer; and 2) a long-wear cosmetic composition comprising at least one silicone-polyamide copolymer, at least one silicone film former, and at least one volatile oil. Methods comprise applying the compositions of the systems on to the skin sequentially after a drying period.

Abstract: The disclosure relates to compositions and methods for removing cosmetic films and makeup compositions from keratinous fibers. Compositions comprise at least one low-viscosity, low-volatility silicone. Methods comprise applying the compositions to keratinous fibers.

Abstract: The disclosure relates to systems and methods for improving the appearance of the skin. Systems comprise a skin-tightening composition comprising at least one thermoplastic elastomer, at least one adhesive polymer, and at least one filler, and a cosmetic composition comprising at least one colorant and optionally at least one volatile solvent. Methods comprise applying the compositions of the systems on to the skin.

Abstract: Compositions containing at least one sunscreen active agent and having improved sun protection factor (SPF) properties, as well as methods of improving sun protection factor (SPF) properties of compositions containing at least one sunscreen active agent, are provided.

Abstract: Compositions containing at least one sunscreen active agent and having improved water resistance properties, as well as methods of improving water resistance properties of compositions containing at least one sunscreen active agent, are provided.

Abstract: Compositions containing at least one sunscreen active agent and having improved sun protection factor (SPF) properties, as well as methods of improving sun protection factor (SPF) properties of compositions containing at least one sunscreen active agent, are provided.

Abstract: Described herein is a physiologically-balanced, acidic solution. Typically the solution is prepared by a chemical reactions or by the electrolysis of a solution comprising a mixture of an inorganic salt to form a physiologically balanced solution. This invention also relates to methods for use of the solutions, including a specialized bandage which may be used in combination with the solutions, or optionally with other topically applied materials. A mixture of inorganic salts and, optionally minerals, is used in order to mimic the electrolyte concentration and mixture of body fluid in an isotonic state. The solution typically comprises of one halide salt of lithium, sodium, potassium, calcium, and other cations. Typically the halide is fluoride, chloride, bromide, or iodide, and most typically chloride.

Abstract: Novel monoamine oxidase B inhibitors of formula (I), wherein R.sub.1 .dbd.H, an optionally substituted benzyloxy or phenylethoxy group; p=0-3; R.sub.3 .dbd.H, a CN, OH, CCH group, a C.sub.1 -C.sub.3 alkoxy-carbonyl group, or a C.sub.1 -C.sub.3 alkylated cyanomethyl group; R.sub.2 .dbd.H or a C.sub.1 -C.sub.3 alkyl group; n=0 or 1; if n=0, R.sub.4 is a C.sub.1 -C.sub.3 alkyl group or a C.sub.1 -C.sub.3 alkoxy group, while if n=1, y=1 and R.sub.4 is a C.sub.1 -C.sub.3 alkyl group, a C.sub.1 -C.sub.3 alkoxy group or a phenyl group. The invention also concerns processes for the preparation of said novel inhibitors and the therapeutic use thereof.